Calendar of Events & Lectures

Today
This Week

Friday, May 5, 2017

Centrosomal Proteins Mutated in Human Inherited Retinal Disorders

| 101 ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.
Tri-Institutional Events (at MSK & WCM), Cell Biology Seminars
Hidden Genetic Variation: Hereditary Blindness as a Model
Elfride De Baere, Ph.D., professor, Center for Medical Genetics, Ghent University Hospital

mRNA Degradation in Synaptic Plasticity

| M-107 MSKCC, 1275 YORK AVE.
Tri-Institutional Events (at MSK & WCM), Molecular Biology Seminars
Dilek Colak, Ph.D., assistant professor of neuroscience, department of pediatrics and Brain and Mind Research Institute, Weill Cornell Medical College

How Does Light Stimulate Sensory Hair Cells?

| CARSON FAMILY AUDITORIUM (CRC)
Academic Lectures, Thesis Presentations
Julien Azimzadeh, biomedical fellow, The Rockefeller University

Sensing Tension at Kinetochores

| CASPARY AUDITORIUM
Academic Lectures, Friday Lecture Series
Sue Biggins, Ph.D., member and associate director, division of basic sciences, Fred Hutchinson Cancer Research Center; investigator, Howard Hughes Medical Institute

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar